Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

2 registered trials, newest registry update first. Showing only trials linked to J-147.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
Safety and Efficacy of J147 in Acute Ischemic Stroke
NCT07430917
J-147Phase 2RecruitingAbrexa Pharmaceuticals, Inc.196Mar 1, 2028Aug 24, 2026
Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147
NCT03838185
J-147Phase 1CompletedAbrexa Pharmaceuticals, Inc.64Feb 1, 2020Sep 3, 2020

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.